{
    "nctId": "NCT03547089",
    "briefTitle": "A Prospective Trial to Assess Breast Cancer Survivors and Vaginal Atrophy Treatment Outcomes",
    "officialTitle": "A Prospective Trial to Assess Breast Cancer Survivors and Vaginal Atrophy Treatment",
    "overallStatus": "SUSPENDED",
    "conditions": "Vaginal Atrophy, Genitourinary System; Disorder, Female, Vaginal Abnormality, Sexual Dysfunction, Sexual Problem",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 10,
    "primaryOutcomeMeasure": "Sexual dysfunction",
    "eligibilityCriteria": "Key Inclusion Criteria:\n\n* 18 years or older\n* Breast cancer survivors defined as women with a history of hormone sensitive breast cancer on tamoxifen\n* Self-reported vaginal laxity\n* Meet diagnosis of sexual dysfunction\n* Patients must be able to understand and willing to sign a written informed consent document and be willing to complete the patient reported outcome tools at the scheduled time points\n\nExclusion Criteria:\n\n* Cognitive impairment\n* Women currently on chemotherapy and/or radiation or who have had their last chemotherapy within 6 months of the intervention\n* Women with active breast cancer disease\n* Women currently on hormone therapy or who are pregnant\n* Women who have had vaginal or pelvic surgery involving the genitalia",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}